189 related articles for article (PubMed ID: 18253818)
41. Silibinin Radiosensitizes EGF Receptor-knockdown Prostate Cancer Cells by Attenuating DNA Repair Pathways.
Rajput M; Mishra D; Kumar K; Singh RP
J Cancer Prev; 2022 Sep; 27(3):170-181. PubMed ID: 36258717
[TBL] [Abstract][Full Text] [Related]
42. Silibinin suppresses growth of human prostate carcinoma PC-3 orthotopic xenograft via activation of extracellular signal-regulated kinase 1/2 and inhibition of signal transducers and activators of transcription signaling.
Singh RP; Raina K; Deep G; Chan D; Agarwal R
Clin Cancer Res; 2009 Jan; 15(2):613-21. PubMed ID: 19147767
[TBL] [Abstract][Full Text] [Related]
43. Androgen-independent prostate cancer cells circumvent EGFR inhibition by overexpression of alternative HER receptors and ligands.
Carrión-Salip D; Panosa C; Menendez JA; Puig T; Oliveras G; Pandiella A; De Llorens R; Massaguer A
Int J Oncol; 2012 Sep; 41(3):1128-38. PubMed ID: 22684500
[TBL] [Abstract][Full Text] [Related]
44. The mitogen-activated protein (MAP) kinases p38 and extracellular signal-regulated kinase (ERK) are involved in hepatocyte-mediated phenotypic switching in prostate cancer cells.
Ma B; Wells A
J Biol Chem; 2014 Apr; 289(16):11153-11161. PubMed ID: 24619413
[TBL] [Abstract][Full Text] [Related]
45. Retinoids suppress epidermal growth factor-associated cell proliferation by inhibiting epidermal growth factor receptor-dependent ERK1/2 activation.
Sah JF; Eckert RL; Chandraratna RA; Rorke EA
J Biol Chem; 2002 Mar; 277(12):9728-35. PubMed ID: 11788593
[TBL] [Abstract][Full Text] [Related]
46. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
[TBL] [Abstract][Full Text] [Related]
47. Silibinin strongly synergizes human prostate carcinoma DU145 cells to doxorubicin-induced growth Inhibition, G2-M arrest, and apoptosis.
Tyagi AK; Singh RP; Agarwal C; Chan DC; Agarwal R
Clin Cancer Res; 2002 Nov; 8(11):3512-9. PubMed ID: 12429642
[TBL] [Abstract][Full Text] [Related]
48. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
Singh RP; Gu M; Agarwal R
Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
[TBL] [Abstract][Full Text] [Related]
49. ErbB-2 signaling plays a critical role in regulating androgen-sensitive and castration-resistant androgen receptor-positive prostate cancer cells.
Muniyan S; Chen SJ; Lin FF; Wang Z; Mehta PP; Batra SK; Lin MF
Cell Signal; 2015 Nov; 27(11):2261-71. PubMed ID: 26257301
[TBL] [Abstract][Full Text] [Related]
50. Isosilybin B and isosilybin A inhibit growth, induce G1 arrest and cause apoptosis in human prostate cancer LNCaP and 22Rv1 cells.
Deep G; Oberlies NH; Kroll DJ; Agarwal R
Carcinogenesis; 2007 Jul; 28(7):1533-42. PubMed ID: 17389612
[TBL] [Abstract][Full Text] [Related]
51. EGFR ligand switch in late stage prostate cancer contributes to changes in cell signaling and bone remodeling.
DeHaan AM; Wolters NM; Keller ET; Ignatoski KM
Prostate; 2009 Apr; 69(5):528-37. PubMed ID: 19143022
[TBL] [Abstract][Full Text] [Related]
52. Silibinin inhibits constitutive and TNFalpha-induced activation of NF-kappaB and sensitizes human prostate carcinoma DU145 cells to TNFalpha-induced apoptosis.
Dhanalakshmi S; Singh RP; Agarwal C; Agarwal R
Oncogene; 2002 Mar; 21(11):1759-67. PubMed ID: 11896607
[TBL] [Abstract][Full Text] [Related]
53. Comparative analysis of mRNA and protein expression for epidermal growth factor receptor and ligands relative to the proliferative index in human prostate tissue.
Glynne-Jones E; Goddard L; Harper ME
Hum Pathol; 1996 Jul; 27(7):688-94. PubMed ID: 8698313
[TBL] [Abstract][Full Text] [Related]
54. The effect of tyrosine kinase inhibitors, tyrphostins: AG1024 and SU1498, on autocrine growth of prostate cancer cells (DU145).
Kisielewska J; Ligeza J; Klein A
Folia Histochem Cytobiol; 2008; 46(2):185-91. PubMed ID: 18519236
[TBL] [Abstract][Full Text] [Related]
55. Bispecific antisense oligonucleotides having binding sites directed against an autocrine regulated growth pathway and bcl-2 for the treatment of prostate tumors.
Rubenstein M; Tsui P; Guinan P
Med Oncol; 2007; 24(2):189-96. PubMed ID: 17848743
[TBL] [Abstract][Full Text] [Related]
56. Tyrphostin AG825 triggers p38 mitogen-activated protein kinase-dependent apoptosis in androgen-independent prostate cancer cells C4 and C4-2.
Murillo H; Schmidt LJ; Tindall DJ
Cancer Res; 2001 Oct; 61(20):7408-12. PubMed ID: 11606371
[TBL] [Abstract][Full Text] [Related]
57. Expression of mRNA for epidermal growth factor, transforming growth factor-alpha and their receptor in human prostate tissue and cell lines.
Ching KZ; Ramsey E; Pettigrew N; D'Cunha R; Jason M; Dodd JG
Mol Cell Biochem; 1993 Sep; 126(2):151-8. PubMed ID: 7508078
[TBL] [Abstract][Full Text] [Related]
58. Autocrine regulation of steroidogenic function of Leydig cells by transforming growth factor-alpha.
Millena AC; Reddy SC; Bowling GH; Khan SA
Mol Cell Endocrinol; 2004 Sep; 224(1-2):29-39. PubMed ID: 15353178
[TBL] [Abstract][Full Text] [Related]
59. Silibinin inhibits fibronectin induced motility, invasiveness and survival in human prostate carcinoma PC3 cells via targeting integrin signaling.
Deep G; Kumar R; Jain AK; Agarwal C; Agarwal R
Mutat Res; 2014 Oct; 768():35-46. PubMed ID: 25285031
[TBL] [Abstract][Full Text] [Related]
60. Response to transforming growth factor alpha (TGFalpha) and epidermal growth factor (EGF) in hepatocytes: lower EGF receptor affinity of TGFalpha is associated with more sustained activation of p42/p44 mitogen-activated protein kinase and greater efficacy in stimulation of DNA synthesis.
Thoresen GH; Guren TK; Sandnes D; Peak M; Agius L; Christoffersen T
J Cell Physiol; 1998 Apr; 175(1):10-8. PubMed ID: 9491776
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
